Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

PHASE2RecruitingINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 8, 2022

Primary Completion Date

May 8, 2026

Study Completion Date

May 8, 2026

Conditions
Recurrent Nasopharyngeal Carcinoma
Interventions
PROCEDURE

endoscopic surgery

endoscopic surgery combined with adjuvant immunotherapy with/without chemotherapy

Trial Locations (8)

200031

RECRUITING

Eye& ENT Hospital, Fudan University, Shanghai

Unknown

NOT_YET_RECRUITING

The First Affiliated Hospital of USTC(University of Science and Technology of China), Hefei

NOT_YET_RECRUITING

Fujian Medical University Union Hospital, Fuzhou

NOT_YET_RECRUITING

Fujian Provincial Hospital, Fuzhou

NOT_YET_RECRUITING

Shenzhen Second People's Hospital, Shenzhen

NOT_YET_RECRUITING

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

NOT_YET_RECRUITING

Shanghai Zhongshan Hospital,Fudan University, Shanghai

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences

OTHER

lead

Eye & ENT Hospital of Fudan University

OTHER